An Era of Innovation: Novel Drugs Redefining Multiple Sclerosis Treatment Paradigm
Since the approval of the first drug, interferon beta 1b (IFNβ-1b), in 1993, the treatment landscape of multiple sclerosis (MS) has significantly changed. Currently, there exist more than 20 disease-modifying...



